Abstract-The gate control theory proposed that the nociceptive sensory information transmitted to the brain relies on an interplay between the inputs from nociceptive and non-nociceptive primary afferent fibers. Both inputs are normally under strong inhibitory control in the spinal cord. Under healthy conditions, presynaptic inhibition activated by non-nociceptive fibers modulates the afferent input from nociceptive fibers onto spinal cord neurons, while postsynaptic inhibition controls the excitability of dorsal horn neurons, and silences the non-nociceptive information flow to nociceptive-specific (NS) projection neurons. However, under pathological conditions, this spinal inhibition may be altered and lead to chronic pain. This review summarizes our knowledge of presynaptic inhibition in pain control, with particular focus on how its alteration after nerve or tissue injury contributes to neuropathic or inflammatory pain syndromes, respectively.
SPINAL INHIBITION
Chronic pain may not be one of the leading causes of death, such as cardiovascular disease, cancer, and diabetes (WHO, 2008) , but it affects more people than these three diseases together, i.e. 116 million adults in the U.S. and 20% of the adult European population (Breivik et al., 2006; Institute of Medicine, 2011) . It highly impairs patients' mood, quality of life, activities of daily life and performance at work. The annual cost of chronic pain is $560-635 billion in the U.S, higher than the costs of cardiovascular diseases, cancers, and diabetes combined (Institute of Medicine, 2011) . Unfortunately the treatments currently covered by such an enormous expense do not fully alleviate patients' suffering and often elicit numerous side effects. A focus on understanding and targeting the underlying molecular and cellular mechanisms of chronic pain is urgently required. In the last decade, remarkable efforts have been made and important conceptual advances have been achieved, among which, loss of inhibition in the dorsal horn of the spinal cord is widely accepted as a key mechanism contributing to the initiation and maintenance of chronic pain (Enna and McCarson, 2006; Zeilhofer et al., 2012; Bonin and De Koninck, 2013) .
Spinal nociceptive processing
Spinal dorsal horn is the first relay in the central nervous system (CNS) where nociceptive input from primary sensory afferents is integrated and further transmitted to higher brain centers, where conscious pain perception arises. Determined by their axon size and sensory modalities, the primary afferents terminate in different laminae of the dorsal horn (Todd, 2010) . Generally speaking, the superficial dorsal horn (laminae I-IIo) is mostly innervated by nociceptive fibers, whereas fibers from low-threshold mechanoreceptors mainly terminate in the deep dorsal horn (laminae IIi-V). Projection neurons are mostly located in laminar I and scattered throughout laminae III-VI. Surprisingly, despite their importance in transmitting information to the brain, projection neurons only make up a small proportion of the neurons in the spinal cord, e.g. nociceptive-specific (NS) projection neurons compose 5% of lamina I neurons (Spike et al., 2003) . The vast majority of neurons in laminae I-III are interneurons. In rats, GABA-immunoreactivity is present in $25%, 30% and 40% of neurons in laminae I, II and III, respectively. Most of the glycine-immunoreactive cell bodies in laminae I-III are also GABA-immunoreactive with the exception of some neurons in lamina III (Polgar et al., 2003) . This abundance of inhibitory interneurons in the spinal cord strongly suggests an important functional role of inhibition in pain information processing. About half century ago, Melzack and Wall first proposed that these inhibitory interneurons function as a gate in spinal dorsal horn. The balance between the inputs from nociceptive and non-nociceptive primary fibers which is controlled by the complex spinal inhibitory interneuron circuits determines the status of this gate, i.e. whether and how strong the nociceptive information will be transmitted, via NS projection neurons, to higher brain centers. This inhibitory gate is also responsible for keeping nociceptive and nonnociceptive modalities apart under normal healthy condition ( Fig. 1 ). In line with this, the gate control theory further predicts that under pathological conditions, a disrupt of the spinal inhibitory circuit efficacy may contribute to chronic pain development (Melzack and Wall, 1965) .
Since then, a large body of evidence from pharmacological and behavior studies have confirmed the importance of spinal inhibition in controlling pain information processing. Enhancing spinal GABAergic inhibition by intrathecal application of GABA or a positive allosteric modulator (PAM), such as diazepam (DZP), exhibits a clear antinociceptive effect and reverses chronic pain induced by nerve injury (Roberts et al., 1986; Sawynok, 1987; Malcangio and Bowery, 1996; Dickenson et al., 1997; Zeilhofer et al., 2012) . On the contrary, blockade of GABA-mediated inhibition in the spinal cord produces an increased nociceptive reaction to noxious stimuli (hyperalgesia) and painful sensations to innocuous stimuli (tactile allodynia) (Roberts et al., 1986; Sivilotti and Woolf, 1994; Sorkin et al., 1998; Loomis et al., 2001; Zhang et al., 2001; Malan et al., 2002) . Hyperalgesia and tactile allodynia are the two major symptoms of chronic pain. Thus diminishing inhibitory pain control in the spinal dorsal horn could replicate the main characteristics of chronic pain states as predicted by the gate control theory. Indeed, a decrease in inhibition, or ''disinhibition'', has been shown as an important substrate of many chronic pain models (Woolf, 2000; Baba et al., 2003; Cervero et al., 2003; Coull et al., 2003; Enna and McCarson, 2006; Gwak and Hulsebosch, 2011; Puri et al., 2012; Zeilhofer et al., 2012; Bardoni et al., 2013; Bonin and De Koninck, 2013; Lu et al., 2013) . This disinhibition results in a general increase in the excitability of networks of neurons, and can allow activation of sensory pathways that are normally silenced by inhibition, such as the excitatory input from non-nociceptive fibers to NS projection neurons in lamina I.
Spinal GABAergic inhibition
The GABA A receptor can modulate spinal nociceptive processing via two mechanisms: GABA A receptors located in primary afferent terminals of nociceptors cause reduction in transmitter release thus modulating the afferent input from DRG neurons into NS projection neurons (presynaptic inhibition), while postsynaptic GABA A receptors in spinal cord neurons directly reduce their excitability and therefore control the output (postsynaptic inhibition). Both pre-and postsynaptic inhibition are controlled by local inhibitory interneurons and inhibitory descending fibers . While there is growing evidence indicating that spinal inhibition contributes to physiological and pathological pain sensation (Enna and McCarson, 2006; Knabl et al., 2008; Munro et al., 2011; Zeilhofer et al., 2012; Bardoni et al., 2013; Bonin and De Koninck, 2013; Braz et al., 2014 ), the precise contribution of different modes of inhibition (pre vs. post) in various pain modalities is not known. This is mainly due to the difficulties to selectively manipulate pre-or postsynaptic inhibition. The postsynaptic inhibition and its role in chronic pain have been intensively reviewed elsewhere (Dickenson et al., 1997; Cattaert et al., 2001; Zeilhofer et al., 2012; Bonin and De Koninck, 2013; Prescott et al., 2014) . In this review, we will focus on presynaptic inhibition and its alteration after tissue or nerve injury.
PRESYNAPTIC INHIBITION
GABA A receptors expressed on primary sensory neurons GABA A receptors are ligand-gated heteropentameric chloride ion channels encoded by a family of at least 19 subunits (a1-6, b1-3, c1-3, d, e, h, p, q1-3). The most common subtype of GABA A receptors contains two a, two b, and one c subunit. Several lines of evidence indicate that GABA A receptors are present on primary sensory neurons to mediate presynaptic inhibition (Table 1) . In situ hybridization studies localized the mRNA for a2, b3, and c2 subunits in both large-and small-diameter adult rat DRG neurons (Persohn et al., 1991; Ma et al., 1993) . The distribution of GABA A receptors has also been assessed in cultured embryonic and adult human DRGs using reverse-transcript PCR (RT-PCR) which confirmed the expression of a2 and b3 mRNA in both embryonic and adult cultures (Maddox et al., 2004) . These findings provide a molecular basis for the presynaptic inhibition. However, the direct evidence for the expression of different isoforms of GABA A receptors on primary afferent terminals in the spinal cord was not present until a recent study from Zeilhofer's laboratory (Paul et al., 2012) . By utilizing immunohistochemistry with subunit-specific antibodies combined with markers of primary afferents the authors revealed a selective distribution of GABA A receptor subunits a1-3 and a5 Fig. 1 . Balance between primary afferent-derived excitatory and inhibitory drives to the spinal cord dorsal horn. Stimulation of non-nociceptive Ab fibers induces activation of inhibitory interneurons 1 and 2. GABA release from neuron 1 which is possibly GAD65 positive as discussed in review causes the activation of GABA A receptors expressed on C and Ad nociceptive afferent terminals, leads to the generation of PAD and therefore inhibition of glutamate release onto nociceptive-specific (NS) projection neuron (presynaptic inhibition). Neuron 2 directly establishes synaptic connections to NS projection neurons and reduces its excitability thus controlling the output (postsynaptic inhibition). There also exists a normally silent excitatory linkage from non-nociceptive Ab fibers to PKCc + cell and further to excitatory interneuron. This connection is inhibited by glycinergic interneuron 3 which receives input from low-threshold Ab fibers as well. In the setting of nerve injury, the postsynaptic inhibition derived from neurons 2 and 3 are disrupted through various mechanisms. Therefore the innocuous inputs gain access to the nociceptive pathway and activate NS projection neuron, leading to tactile allodynia. In parallel, [Cl À ] i in primary afferents is upregulated accompanied by a reduction of GABA A receptor conductance, leading to a loss of presynaptic inhibition, hence, heat hyperalgesia. In the setting of tissue injury, [Cl À ] i in primary afferents is upregulated as well as GABA A receptor conductance. Inputs from non-nociceptive Ab fibers could then, via GABAergic interneurons 1, evoke action potentials in nociceptive afferents, from where excitation could spread both anterogradely and retrogradely (as DRR), to induce touch-evoked pain and neurogenic inflammation. (Paul et al., 2012) .
Function of presynaptic inhibition
Evidence supporting an analgesic action of spinal GABA A receptor activation comes from local injection of muscimol or GABA at the spinal cord level which reduces nociceptive responses (Roberts et al., 1986; Dickenson et al., 1997; Wei et al., 2010) . Moreover, the phenotype of pain behavior in GABA A receptor b3 subunit knockout (GABRB3
) mice displays an increased sensitivity to heat and mechanical stimuli (Ugarte et al., 2000) . However, none of these studies made a clear distinction between pre-and postsynaptic inhibition. First effort has been nicely made again by Zeilhofer's laboratory. They have applied a genetic approach to selectively knockout presynaptic GABA A receptor a2 subunit on spinal nociceptor terminals (sns-a2 À/À mice) in order to address the contribution of presynaptic inhibition to spinal pain control (Witschi et al., 2011) . Ablation of a2-GABA A receptors almost completely abolished the potentiating effect of the positive allosteric GABA A receptor modulator DZP on primary afferent depolarization (PAD) and its spinal antihyperalgesic action against inflammatory hyperalgesia was also reduced. It is known that GABA A receptors containing a1, a2, a3, or a5 subunits associated with the c2 subunit are sensitive to DZP . Thus this study provided evidence that the antihyperalgesic action of spinally applied DZP occurs largely through facilitating presynaptic inhibition (Witschi et al., 2011) . Surprisingly, GABAergic membrane currents recorded from nociceptive DRG neurons are the same between WT and sns-a2 À/À mice. Furthermore, snsa2 À/À mice exhibited normal response thresholds to thermal and mechanical stimulation, and developed normal inflammatory and neuropathic pain. This might be due to the upregulation of benzodiazepine-insensitive GABA A receptor subunits which made this transgenic mouse model not suitable for directly demonstrating the function of presynaptic inhibition in spinal pain control.
As we have noted above, b3 subunit has been shown by different studies as the most dominant b subunit expressed in DRG neurons. So we sought to generate a new mouse line in which GABA A receptor b3 subunit is selectively knocked out in primary nociceptors (snsb3 À/À mice). The amplitude of GABA A receptor current is significantly reduced in sns-b3 À/À mice compared to wild-type mice demonstrating a functional loss of presynaptic GABA A receptors. Intriguingly, sns-b3 À/À mice exhibited a hypersensitive phenotype to both noxious heat and mechanical stimulation compared to wild-type mice. In contrast, acute sensitivity to cold stimulus is not affected in sns-b3 À/À mice (Chen et al., 2014) . To our knowledge, this is the first in vivo evidence showing the presynaptic GABA A receptor is required for controlling both heat and mechanical pain signal processing under healthy condition.
Mechanisms of presynaptic inhibition
Activation of GABA A receptors opens ligand-gated chloride ion channels. In the nervous system, the strength and polarity of GABA-mediated neurotransmission largely depend on the intracellular chloride concentration [Cl À ] i . And the [Cl À ] i is determined, in part, by the activities of cation-chloride cotransporters (CCCs) including the inwardly directed Na-K-2Cl cotransporter (NKCC1) and various outwardly directed K-Cl cotransporters, such as KCC2 and KCC3 (Kahle et al., 2008) . During CNS maturation, GABAergic signaling switches from excitatory to inhibitory by controlling the KCC2 activity relative to NKCC1 activity (Kahle et al., 2008; Benarroch, 2013) . Unlike neurons in the adult central nervous system, under physiological conditions, NKCC1 is still expressed at high levels in DRG neurons while KCC2 and KCC3 are expressed at low levels or even absent (Alvarez-Leefmans et al., 2001; Kanaka et al., 2001; Price et al., 2006; Mao et al., 2012) . As a consequence, DRG neurons maintain a high level of [Cl À ] i which results in a positive equilibrium potential for chloride E Cl relative to neuron's resting membrane potential (V m ), so the opening of chloride channels on primary afferent terminals by GABA causes net chloride efflux and consequently depolarizes the neurons. However this PAD inhibits rather than facilitates transmitter release from the primary afferent terminal. Different mechanisms have been proposed to explain how GABA-mediated PAD produces presynaptic inhibition: (1) PAD may lead to the inactivation of voltage-gated sodium (NaV) channels on primary afferent axons and/or terminals and thus interrupt orthodromic propagation of action potentials from periphery; (2) PAD may attenuate the amplitude of propagated action potentials through an increase in membrane conductance produced by opening chloride channels (shunting) thus ultimately reducing transmitter release to the second-order neurons in the spinal dorsal horn; (3) Alternatively, PAD may inactivate the voltage-gated calcium channels on terminals thus reducing presynaptic calcium influx and transmitter release (Rudomin and Schmidt, 1999; Price et al., 2009; Zeilhofer et al., 2012) . However, the relative contribution of these three mechanisms to presynaptic inhibition in primary nociceptors is still under debate (Cattaert and El Manira, 1999; Willis, 1999 Willis, , 2006 Cattaert et al., 2001; Panek et al., 2002; French et al., 2006) . The inactivation of the NaV channels by depolarization depends on the biophysical properties of the channels expressed in primary sensory neurons. Most NaV channels expressed in large diameter (non-nociceptive) sensory fibers are subject to steady-state inactivation over a voltage-range spanning typical resting membrane potential (i.e., À80 to À50 mV). In contrast, high density of tetrodotoxin-resistant (TTX-R) NaV channels which are resistant to steady-state inactivation are detected in central terminals of nociceptive fibers (Jeftinija, 1994; Gold et al., 1996; Zhu et al., 2012) . This raises the question whether GABA-induced depolarization could effectively inactivate the major TTX-R NaV channels expressed in nociceptive primary afferents and block action potential propagation. The depolarization effect has also been studied via investigating the functional role of NKCC1 in nociceptive processing. DRG neurons isolated from NKCC1-KO mice exhibited a negatively shifted E GABA implicating a reduced depolarization by GABA in neurons lacking NKCC1. Interestingly, NKCC1 mutant mice display significant increased latencies to withdrawal from noxious heat in the hot plate test and tail flick test, paradoxically suggesting a further inhibitory effect by reduced PAD amplitude (Sung et al., 2000; Laird et al., 2004) . However, NKCC1-KO mice show major deficits in motor coordination (Sung et al., 2000) , therefore, more selective manipulation of NKCC1 is needed to gain a better understanding of the role of NKCC1 in presynaptic inhibition and thermal nociception.
Under physiological conditions, afferent inputs from non-nociceptive neurons, via interconnected spinal inhibitory interneurons, control the gate of nociceptive information flow by pre-and postsynaptic inhibition, thus touch could close the gate of pain, or reduce pain (Fig. 1 ). In addition, there exists a closed gate from lowthreshold Ab fibers to NS projection neurons in lamina I. Both inhibitory and excitatory Ab fiber inputs converge onto PKC Y + neurons in the superficial dorsal horn to form a feed-forward inhibitory circuit which prevents Ab input from activating the nociceptive pathway ( Fig. 1 ) (Malan et al., 2002; Miraucourt et al., 2007; Bardoni et al., 2013; Lu et al., 2013) . Under chronic pain conditions, the status of these gates may be changed. There is ample evidence indicating that a reduction of spinal inhibition or in extreme case even a switch to excitation is a powerful contributing factor to neuropathic and inflammatory pain. Considerable studies which investigated the effect of modulating GABA transmission on chronic pain have been reported, however, yielding conflicting results. Several reports have demonstrated GABA or GABA A receptor PAMs mediate robust analgesia, whereas others have found GABA or PAM exacerbate pain syndromes (Bianchi et al., 1993; Rode et al., 2005; Knabl et al., 2008; Munro et al., 2009 Munro et al., , 2011 Mirza and Munro, 2010) . Since most inconsistency come from inflammatory pain studies, a possible explanation is that different injury modes (e.g. nerve injury vs. tissue injury) may lead to different alterations of pre-and/or postsynaptic inhibition underlying neuropathic pain and inflammatory pain, respectively.
PRESYNAPTIC DISINHIBITION IN NEUROPATHIC PAIN
Recent years have seen accumulating evidence suggesting that diminished postsynaptic inhibition plays a key role in neuropathic pain development and maintenance. For example, loss of inhibition on PKC Y + neurons after nerve injury allows low-thresholdmechanoreceptor signals to gain access to the NS pathway, an opening of a before-closed gate ( Fig. 1 ) (Melzack and Wall, 1965; Miraucourt et al., 2007; Kahle et al., 2008) . This may explain the phenomena of tactile allodynia. The precise basis for the diminished postsynaptic inhibition remains to be determined, with reduced descending inhibitory control, loss of GABAergic interneurons, decreased GABA release, reduced GABA or GABA synthesizing enzyme (glutamate decarboxylase (GAD)), altered postsynaptic GABA A receptors and CCC within the spinal cord, all having been proposed as possible mechanisms (Roberts et al., 1986; Castrolopes et al., 1993; Eaton et al., 1998; Fukuoka et al., 1998; Lever et al., 2003; Polgar et al., 2003; Munro et al., 2009; Wang et al., 2013) . However, despite the change of postsynaptic GABA A receptors and CCCs, diminished spinal GABAergic tone would unavoidably affect presynaptic inhibition, as well as postsynaptic inhibition. Of particular interest is the downregulation of GAD65 expression in the dorsal horn. GAD65 (65 kDa) and GAD67 (67 kDa) are two isoforms of GAD and are commonly co-expressed in GABAergic interneurons. At sensory-motor synapses in the ventral horn, GAD65 has been shown exclusively associated with terminals presynaptic to primary afferents whereas GAD67 is associated in addition with GABAergic terminals that form synapses with dendrites and somata (Betley et al., 2009 ). Intriguingly, after nerve injury, GAD65 mRNA and protein levels declined significantly in all laminae of the ipsilateral dorsal horn while GAD67 levels did not differ (Eaton et al., 1998; Braz et al., 2012) . It would be very interesting to check, whether GAD65 is also exclusively expressed in the inhibitory boutons that contact sensory terminals in the superficial dorsal horn. If yes, the downregulation of GAD65 but not GAD67 after nerve injury would imply a specific reduction of presynaptic inhibition rather than of a postsynaptic inhibition.
Altered GABA A receptor conductance and E GABA As noted above, the capacity for neuronal inhibition by GABA A receptor activation is critically dependent on [Cl À ] i . Recent work demonstrates that neuropathic pain involves the rapid downregulation of KCC2, leading to an increase of [Cl À ] i and ultimately produce a reduction of postsynaptic inhibition thus increases the excitability of spinal dorsal horn neurons (hyperalgesia) and unmask non-nociceptive input onto normally NS pathway (tactile allodynia). However, an increased activity of NKCC1 and a depolarizing shift of E GABA in DRG neurons have also been observed after nerve injury in several studies including our own (Table 2) (Pieraut et al., 2007 (Pieraut et al., , 2011 Wei et al., 2013; Anseloni and Gold, 2008; Chen et al., 2014; Panek et al., 2002; Modol et al., 2014) . Despite the fact that increased [Cl À ] i is required for neuronal regeneration after peripheral nerve injury (Pieraut et al., 2007) , the shifted E GABA might produce an enhanced PAD which can increase excitability of primary nociceptors (hyperalgesia) or even become sufficient enough to directly evoke an action potential, thus transforming an inhibitory process into an excitatory one (tactile allodynia) (Cervero et al., 2003) . In vertebrate primary afferent axons, activation of presynaptic GABA A receptors causes depolarization and increases membrane conductance (shunting). As we have discussed above, both PAD and shunting may contribute to presynaptic inhibition. Thus, besides the alteration of E GABA in DRG neurons, a regulation of GABA A receptors following nerve injury may also be an important cause of neuropathic pain. Indeed, both GABA A receptor a2 and c2 subunits have been reported to be downregulated after nerve injury (Fukuoka et al., 1998; Obata et al., 2003; Lian et al., 2012) . Recently, we have performed electrophysiological recordings in DRG neurons isolated from injured mice and observed a decreased GABA A receptor conductance (G GABA ) in parallel with a depolarizing shifted E GABA , both lead to the same alteration of GABA A receptor function in primary afferents after nerve injury, i.e. a loss of presynaptic inhibitory effect (Lian et al., 2012; Chen et al., 2014) . Furthermore, we found that these changes in G GABA and E GABA of DRG neurons are rather transient and not maintained at later stages, while persistent neuropathic pain is still present. This observation is in agreement with a NKCC1 transient upregulation after nerve injury reported by Modol et al. (2014) ). In addition, Modol et al. also found that blocking NKCC1 by bumetanide prevented the decrease in KCC2 activity in the spinal cord, suggesting that the augmented activity of NKCC1 in DRG is relevant for the downregulation of pKCC2 in central areas (Ma et al., 1993; Modol et al., 2014) . Factoring all these together, it seems that the transient modulation of presynaptic inhibition is required for the initiation of neuropathic pain, but not for the maintenance of pain when increased excitability of projecting central areas may play a key role.
Loss of presynaptic inhibition but no switch to presynaptic excitation
It has been demonstrated that after nerve injury, the shift of E GABA in spinal cord neurons could switch postsynaptic inhibition into excitation (Coull et al., 2003) . This raises the question of whether the depolarizing shift of E GABA in presynaptic primary sensory neurons would also lead to an excitatory effect while the conductance of GABA A receptor is reduced. The final consequence of presynaptic inhibition is to reduce the calcium influx thus the transmitter release from presynaptic site. In order to investigate the functional change of presynaptic inhibition in the spinal cord after nerve injury, we sought to perform 2-photon calcium imaging specifically in the primary afferent terminals. To target genetically encoded calcium sensor to primary afferents, we crossed mice carrying the floxed GCaMP3 allele (Ai38) (Zariwala et al., 2012) to a mouse line expressing Cre recombinase from the locus of the sensory neuron-specific gene Advillin (advillin-Cre) (Zurborg et al., 2011) . To record the calcium transients in the primary afferent terminals, we performed 2-photon imaging on the spinal cord slices taken from control or nerve-injured mice (Garcia-Nicas et al., 2006; Chen et al., 2014) . Interestingly, we found that (1) after nerve injury the activation of presynaptic GABA A receptors alone does not become excitatory enough to directly induce Ca 2+ influx thus transmitter release from presynaptic sites. (2) A substantial loss of presynaptic inhibition after nerve injury was observed. The similar phenomenon has been reported by Wei and colleagues in a trigeminal neuropathic pain model where they observed a disinhibition and excitation effect on pre-and post-synaptic GABA actions respectively (Wei et al., 2013) . The loss of presynaptic inhibition rather than switching to presynaptic excitation predicts that after nerve injury, alteration of presynaptic inhibition will lead to an increased sensitivity (hyperalgesia) but not an activation of nociceptive pathway directed by non-nociceptive input (tactile allodynia) (Fig. 1) . However, without knowing the relative contribution of PAD and shunting to presynaptic inhibition under normal condition, it is difficult to attribute how much net disinhibition results from shift of E GABA or reduction of G GABA . A simulation is required to further understand quantitatively how changes in GABA A receptors and NKCC1 affect presynaptic transmitter release, thus facilitate the design of more targeted therapeutic avenues for neuropathic pain treatment.
Heat hyperalgesia is due to presynaptic disinhibition
Reduced GABAergic inhibitory tone in the spinal cord after nerve injury has been well documented. Extensive pharmacological and behavioral evidence show that neuropathic pain can be relieved by increasing spinal inhibition. However, all these evidence only demonstrate that spinal disinhibition is involved in the pathogenesis of neuropathic pain, but without distinguishing the relative contribution of pre-and postsynaptic inhibition. A more specific study was carried out by investigating behavioral phenotype of sns-b3 À/À mice after nerve injury. As mentioned above, specifically knocking out of the GABA A receptor in primary nociceptors led to spontaneous development of mechanical and heat hypersensitivity. Interestingly, the heat hypersensitivity cannot be further sensitized by nerve lesions in snsb3 À/À mice while tactile allodynia developed normally, which is predicted by presynaptic calcium imaging results (Chen et al., 2014) . Thus, after nerve injury, the development of tactile allodynia is mostly due to a loss of postsynaptic inhibition either by an excitatory shift of GABA effect on spinal cord NS projection neurons or unmasking the silent input from non-nociceptive fibers in deep dorsal horn to nociceptive neurons in superficial dorsal horn (Bonin and De Koninck, 2013) , while the heat hyperalgesia is generated by a disruption of presynaptic inhibition (Fig. 1) .
PRESYNAPTIC DISINHIBITION IN INFLAMMATORY PAIN
Spinal disinhibition also occurs in response to tissue injury . It has been well established that peripheral inflammation leads to an upregulation of the pronociceptive and proinflammatory prostaglandin E 2 (PGE 2 ) in the spinal cord dorsal horn. PGE 2 , in turn, specifically reduces strychnine-sensitive glycinergic inhibition via a3 subunit containing glycine receptors (GlyRa3) which are selectively expressed in the superficial dorsal horn (Ahmadi et al., 2002; Muller et al., 2003; Harvey et al., 2004; Reinold et al., 2005) . Indeed, after subcutaneous complete Freund's adjuvant (CFA) injection, mice deficient in GlyRa3 recovered from inflammatory pain sensitization much more quickly than corresponding wild-type mice (Harvey et al., 2004) . However, it is worth mentioning that these mice exhibit normal responses to acute nociceptive stimuli, and they do develop inflammatory pain sensitization as wild-type mice, indicating that GlyRa3-mediated disinhibition is more required for the maintenance of inflammatory pain but not for the initiation. Furthermore, recent studies have shown that PGE 2 -mediated inhibition of GlyRa3 appears to be restricted to inflammatory pain since they were not observed to occur after peripheral nerve injury or acute chemical irritation of C fibers following capsaicin, formalin, or acetic acid injection (Hosl et al., 2006; Zeilhofer et al., 2012) .
Switched presynaptic GABAergic inhibition to excitation
Similar to after nerve injury, a reduction in KCC2 after peripheral inflammation induced by CFA injection has also been reported which can effectively eliminate inhibition mediated by GABA and glycine (Zhang et al., 2008) . As mentioned above, loss of GABA A receptormediated spinal inhibition after injury has been regarded as a key feature that contributes to signs and symptoms of pathological pain for decades. However, the effect of facilitating spinal GABAergic pathway differs between neuropathic pain and inflammatory pain. After nerve injury, most behavioral experiments with systemic or centrally administering GABA A agonists show analgesic effects (Yamamoto and Yaksh, 1993; Hwang and Yaksh, 1997; Eaton et al., 1999; Kontinen and Dickenson, 2000; Stubley et al., 2001; Malan et al., 2002; Miletic et al., 2003; Sokal and Chapman, 2003; Rode et al., 2005; Gwak et al., 2006; Mukhida et al., 2007; Knabl et al., 2008; Naik et al., 2008; Asiedu et al., 2010) . In contrast, paradoxically, both GABA A agonists and GABA A receptor antagonists have been reported to mediate behavioral analgesia after tissue injury (Dirig and Yaksh, 1995; Kaneko and Hammond, 1997; Weng et al., 1998; Carlton et al., 1999; Anseloni and Gold, 2008; Knabl et al., 2008; Boegel et al., 2011; Munro et al., 2011) . It has been suggested that this paradox effect is due to an imbalance of spinal GABA function after tissue damage, i.e. reduced postsynaptic GABAergic inhibition vs. switched presynaptic GABAergic inhibition to excitation. Compared to nerve injury, inflammation may induce a much more intense form of PAD sufficient to trigger action potential and to elicit so-called dorsal root reflexes (DRR), thereby rendering the normal inhibitory effect of PAD into an excitation (Willis, 1999) . Inputs from non-nociceptive fibers could then, via interconnected GABAergic interneurons, evoke action potentials in nociceptive afferents, from where excitation could spread both anterogradely and retrogradely, to induce touch-evoked pain and neurogenic inflammation ( Fig. 1) (Cervero et al., 2003; Price et al., 2005 Price et al., , 2009 Garcia-Nicas et al., 2006) . In this way, GABA A receptor antagonist or compounds capable of negatively modulating GABA A receptor function might possess analgesic activity (Mirza and Munro, 2010; Munro et al., 2011) . Indeed, electrophysiological studies from Willis and Westlund's laboratory described an enhancement of DRRs induced by an experimental inflammation of the joints (Rees et al., 1994 (Rees et al., , 1996 Sluka et al., 1995) . A number of reports have shown that DRR activity not only can be antidromically detected Rees et al., 1996; Lin et al., 2000) contributing to the development of neurogenic inflammation (Rees et al., 1994; Lin et al., 1999; Garcia-Nicas et al., 2001 ), but can also propagate orthodromically causing excitation of second-order neurons in the spinal cord (Cervero and Laird, 1996) . Multiple lines of evidence indicate that PAD is enhanced, through increased NKCC1 activity, in hyperalgesic states leading to the generation of DRRs (Rees et al., 1994 Lin et al., 2000) . Indeed, these DRRs can be blocked by spinal application of GABA A receptor antagonists or NKCC1 inhibitor, bumetanide, confirming that NKCC1-regulated presynaptic GABA activation contributes to DRR generation (Valencia-de Ita et al., 2006) . In line with this, NKCC1 activity has been shown to be upregulated after tissue injury or inflammatory mediator treatment (Table 2) (Galan and Cervero, 2005; Nomura et al., 2006; Funk et al., 2008; Scamps et al., 2008; Kahle et al., 2008; Delpire and Austin, 2010; Schobel et al., 2012) . In addition, NKCC1 knockout mice do not display touch-evoked pain after intradermal capsaicin application (Laird et al., 2004) . Consistent with the increased activity of NKCC1, a depolarizing shifted E GABA in DRG neurons after inflammation has also been recorded (Vaughn and Gold, 2010; Zhu et al., 2012) .
However, as observed under neuropathic pain condition, a depolarizing shift of E GABA alone may lead to a less inhibitory effect of presynaptic inhibition but may not necessarily produce suprathreshold GABAergic depolarization in sensory terminals, yielding cross excitation between low-and high-threshold afferents (Chen et al., 2014 ). An increase in GABA-mediated depolarization also depends on the conductance of presynaptic GABA A receptor. A decreased G GABA combined with a shifted E GABA after nerve injury leads to a loss of presynaptic inhibition but is not sufficient to produce action potentials in nociceptive fibers thus an opening of the nociceptive gate by a non-nociceptive stimulus. Interestingly, in contrast to nerve injury, inflammatory mediators have been shown to potentiate high-affinity GABA A currents in DRG neurons (Lee and Gold, 2012) . In the CFA model of inflammatory pain, the GABA-induced depolarization in DRG neurons has been reported to be significantly enhanced accompanied by an increase in the number of neurons which respond to GABA with a Ca 2+ transient (Zhu et al., 2012) , indicating that GABA becomes a presynaptic excitatory neurotransmitter in some inflammatory pain states.
Tactile allodynia is due to presynaptic disinhibition
Recent work has revealed a good correlation between NKCC1 activity and inflammatory pain (Granados-Soto et al., 2005; Valencia-de Ita et al., 2006; Pitcher and Cervero, 2010; He et al., 2011; Pitcher et al., 2013) , but it remains unproven whether presynaptic GABA A receptors are specifically required to produce the nociceptive pathway activation by non-nociceptive input that may in turn cause the behavioral features of inflammatory pain, such as tactile allodynia. In order to test this, we have compared the behavioral phenotype of sns-b3 À/À mice and their wildtype littermates after CFA injection. Remarkably, sns-b3 À/ À mice did not develop any tactile allodynia while the heat hyperalgesia progressed similar in knockout and wild-type mice (unpublished observation). Compared to wild-type mice, sns-b3 À/À mice show significantly less edema. These observations are consistent with the hypothesis that presynaptic GABA A receptor on nociceptive afferent terminals is the key element of tissue injury-induced inflammation and tactile allodynia (Cervero et al., 2003) .
An alternative explanation of this phenotype in snsb3 À/À mice is an imbalance between inhibitory and excitatory inputs to the nociceptive pathway which ultimately unmasks the otherwise silent excitatory input from non-nociceptive neurons. The fact the strong tactile allodynia can be induced within minutes by disinhibition of spinal networks through acute blockade of spinal GABAergic or glycinergic transmission suggests that there exists a hard-wired pathway which is normally under strong inhibitory control ( Fig. 1) (Kuner, 2010) . Electrophysiological studies show that whereas only high-threshold monosynaptic inputs are found on NS projection neurons under normal circumstances, blockade of local inhibition uncovers substantial Ab, low-threshold fiber inputs, which are polysynaptic (Baba et al., 2003) . The strong inhibition may come from glycinergic input onto PKC Y + neurons in the superficial dorsal horn, but it may also comprise the input from GABAergic interneurons onto excitatory interneurons as shown in Fig. 1 . Any disruption of these inhibitory controls can result in nociceptive circuits being engaged by innocuous stimuli. There is evidence that the GABAergic islet cells receive input from nociceptive C fibers (Nakatsuka et al., 2005; Yasaka et al., 2007; Zheng et al., 2010) which are under presynaptic inhibitory control of Ab fibers. Further on, these islet cells can inhibit other inhibitory interneurons Labrakakis et al., 2009; Zheng et al., 2010) , thus a disinhibitory circuit functions as a gate in controlling the ultimate transmission of the touch information to the NS projection neurons (Yasaka et al., 2007; Labrakakis et al., 2009; Braz et al., 2014) . After injury, the presynaptic inhibition is diminished thus the input to this disinhibitory circuit is increased which will in turn reduce the inhibitory control onto excitatory interneuron, open the gate between Ab fiber and NS projection neurons, and produce touch-induced pain. This is different from nerve injury-induced tactile allodynia which is due to the decreased glycinergic inhibition onto PKC Y + neurons, indicating different groups of neurons thus different circuits are involved in neuropathic and inflammatory pain. For example, Abrahamsen and colleagues demonstrated that different types of primary afferent sensory fibers mediate inflammatory and neuropathic hyperalgesia (Abrahamsen et al., 2008) . In addition, study of a mouse model which lacks many excitatory interneurons in the superficial dorsal horn displays normal inflammatory pain but not neuropathic pain strongly suggests that different subsets of neuronal circuits contribute to tissue and nerve injury-induced heat and mechanical pain (Wang et al., 2013) .
Simulations of postsynaptic inhibition reveal that, after nerve injury, even a small depolarizing shift of E GABA compromises GABAergic inhibitory control of firing rate in spinal cord neurons, because shift of E GABA not only decreases GABA A -mediated hyperpolarization, but also indirectly compromises the capacity of shunting to reduce spiking. The latter effect occurs because shunting-mediated inhibition depends on a competition between two opposing biophysical phenomena: shunting reduces depolarization, thereby decreasing firing rate vs. shunting shortens the membrane time constant, thereby fastening membrane charging and increasing spiking. The second effect predominates when average depolarization is suprathreshold, causing GABA Amediated inputs to become paradoxically excitatory (Prescott et al., 2006) . Given this new understanding of the biophysical mechanisms, one would predict that the decreased G GABA which indicates a reduced shunting effect observed after nerve injury may determine a reduction of inhibition, thus leading to enhanced firing to noxious stimulus (hyperalgesia). On the contrary, an increased G GABA after inflammatory injury would switch presynaptic inhibition to excitation, hence a cross activation of nociceptive pathway by nonnociceptive input (tactile allodynia). These theoretical predictions are consistent with our observation in sns-b3 À/À mice that presynaptic GABA A receptor activation contributes to thermal hyperalgesia after nerve injury but to tactile allodynia after tissue injury. However, as well established for presynaptic inhibition, E GABA is already depolarized in primary afferents and the GABA A receptors are presynaptically located, it is very difficult to make a simple prediction based on the simulations of postsynaptic inhibition. A quantitative and biophysically accurate model specific for presynaptic inhibition is required to decipher this complex interplay between the changes of E GABA and G GABA , and understand how these changes lead to a reduction of inhibition, an enhancement of orthodromic propagation of action potentials from periphery or being sufficient to directly induce action potentials after nerve or tissue injury.
CONCLUSION
Here we provide a comprehensive review of different contributions of presynaptic inhibition to neuropathic and inflammatory pain by integrating recent advances in both chronic pain models. Although the behavioral symptoms of neuropathic pain and inflammatory pain are similar, the underlying mechanisms are not necessarily the same. As we have discussed above, after nerve injury and tissue injury, the spinal presynaptic inhibition undergoes different changes, which result in enhanced behavioral responses to noxious and innocuous stimuli. After nerve injury, a reduction of glycinergic postsynaptic inhibition onto PKC Y + neurons, accompanied by an increased [Cl À ] i in spinal cord neurons which leads to less efficacy of both GABA-and glycine-mediated inhibition would ultimately unmask the input from non-nociceptive fibers to NS projection neurons and produce tactile allodynia. In parallel, there is a depolarizing shift of E GABA and a reduced G GABA in primary sensory afferents, which contributes specifically to the development of heat hyperalgesia but not tactile allodynia. In contrast, after tissue injury, a depolarizing shift of E GABA in conjunction with increased G GABA in primary nociceptors will render presynaptic inhibition into excitation and generate DRR thus contributing to tactile allodynia and neurogenic inflammation. We have also emphasized the importance and urgent need of a mathematic modeling study to understand the relative contribution of changes in intracellular chloride concentration and GABA A receptor expression to chronic pain development. However, it remains to be seen whether the presynaptic inhibition alteration is only a mechanism for a short-term induction of heat hyperalgesia and tactile allodynia or if a similar process could also operate for maintaining the longer lasting phases of chronic pain.
